Single Point Partners’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-4,456
Closed -$355K 129
2023
Q1
$355K Sell
4,456
-138
-3% -$9.79K 0.08% 95
2022
Q4
$311K Buy
+4,594
New +$269K 0.07% 104
2022
Q3
Sell
-3,588
Closed -$200K 142
2022
Q2
$200K Buy
+3,588
New +$199K 0.05% 122

Other funds holding NVO

Single Point Partners's NVO Position: Q2 2023 in Review

Single Point Partners sold out of Novo Nordisk (NVO) in Q2 2023, closing a stake of 4,456 shares — an estimated $355K sold.

Single Point Partners first reported a position in NVO in Q2 2022 and held it in 3 quarters. The position peaked at $355K in Q1 2023. 1,197 funds tracked by Wall St. Rank hold NVO as of Q2 2023.

  • Single Point Partners reported no remaining Novo Nordisk position as of Q2 2023 after selling out during the quarter.
  • Single Point Partners sold 4,456 Novo Nordisk shares in Q2 2023, an estimated $355K.
  • Single Point Partners first reported a position in Novo Nordisk in Q2 2022 and held it in 3 quarters.
  • Single Point Partners's Novo Nordisk position peaked at $355K in Q1 2023.
  • 1,197 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2023.

Based on Single Point Partners's 13F filing for Q2 2023, filed 10 Jul 2023.